Bleeding Diathesis With Normal aPTT/PT Profile (Esoterix)
Use
To assist in the determination of a cause of bleeding in a patient with normal aPTT and PT.
Special Instructions
Not provided.
Limitations
This test may be considered investigational by Medicare and other carriers, and might not be covered under insurances as a benefit for patients. The results depend on proper specimen collection and handling, and factors not included in the test could also contribute to bleeding disorders.
Methodology
Other
Biomarkers
LOINC Codes
- 3209-4 - Fact VIII Act/Nor PPP
- 49865-9 - Fact VIII Act/Nor PPP Chro
- 3187-2 - Fact IX Act/Nor PPP
- 3226-8 - Fact XI Act/Nor PPP
- 27815-0 - Fact XIII Act/Nor PPP Chro
- 3255-7 - Fibrinogen PPP-mCnc
- 6014-5 - vWF Act/Nor PPP Aggr Rst act
- 27816-8 - vWF Ag Act/Nor PPP IA
- 27810-1 - Plasm Inhib Act/Nor PPP Chro
- 5975-8 - PAI1 Ag PPP IA-aCnc
- 40454-1 - Clot Lysis PPP Ql
Result Turnaround Time
7-15 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
7 mL
Minimum Volume
Not provided
Container
Blue-top (sodium citrate) tube
Collection Instructions
Plasma must be separated from cells within 45 minutes of venipuncture and plasma centrifuged a second time before being placed in plastic transport tubes. Freeze within two hours and keep frozen until testing is performed.
Storage Instructions
Freeze.
Causes for Rejection
Noncitrated plasma; gross hemolysis; fibrin clot in plasma
Other tests from different labs that may be relevant